Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia
03 févr. 2025 11h03 HE
|
Nordicus Partners Corporation
BEVERLY HILLS, California, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bio-Convert ApS (“Bio-Convert”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial...
Oricidin Launches Groundbreaking Dental Gel for Long-Term Periodontitis Treatment
28 janv. 2025 11h25 HE
|
Nordicus Partners Corporation
BEVERLY HILLS, California, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S, a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company...
Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin’s Breakthrough Treatment for Periodontitis
14 janv. 2025 14h00 HE
|
Nordicus Partners Corporation
BEVERLY HILLS, California, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting...
Nordicus Partners Corporation Acquires the Remaining 5% Shares In Orocidin A/S
12 nov. 2024 09h15 HE
|
Nordicus Partners Corporation
Beverly Hills, California., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...
Nordicus Partners Corporation Acquires Bio-Convert ApS
11 nov. 2024 14h50 HE
|
Nordicus Partners Corporation
Beverly Hills, California., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...
Nordicus Partners Corporation Announces Reverse Stock Split
07 nov. 2024 09h15 HE
|
Nordicus Partners Corporation
Beverly Hills, California., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...
Nordicus Partners To Host Investor Relations Webinar on July 10, 2024
03 juil. 2024 09h15 HE
|
Nordicus Partners Corporation
Beverly Hills, California., July 03, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...
Orocidin – New Insights Into The Treatment Of Periodontitis
11 juin 2024 09h15 HE
|
Nordicus Partners Corporation
Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
04 juin 2024 13h53 HE
|
Nordicus Partners Corporation
Beverly Hills, California, June 04, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...
Nordicus Partners Corporation Acquires 95% Stake in Orocidin A/S
15 mai 2024 12h29 HE
|
Nordicus Partners Corporation
Beverly Hills, California., May 15, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...